Concord Biotech Limited IPO Message Board (Page 48)

API company, hmm...
I burnt my fingers in Glenmark not very far back.

Sir , both are API but in this business there are many types , Concord alag he .

Agar aapko risk jyada lag rahi he to sirf listing gains ke liye lagao , long term badme dekh lenge

CONCORD BIOTECH IPO

Date : 4-8 Aug
Size : 1569.4 cr ( OFS )
Price band : 700-750
M.cap post issue : 7846.2 cr
PE : 32.68
Listing : 17 Aug
Retail : 35%

Selling shareholder : Helix investments

Peers-
1.Divis Lab : 54.37
2.Gland Pharma : 27.33.Glenmark Life : 16.2
4.Suven Pharma : 30.6
5.Laurus Labs : 23.03
6.Shilpa Medicare : Nil7.Natco Pharma: 21.10

Facts : 1. Concord biotech's biggest rival globally is Almac Group (UK) which recently concluded its IPO in South Korean Markets
Which skyrocketed by 12% after info of Concord biotech's IPO , maybe a COINCIDENCE

2.Rakesh Jhunjhunwala's Family owns 24.09% equity of the company who are highest equity holder after promoter
Sudhir Vaid ( 28.84% )

Nice information
Appreciated sir👍

@newgen consultancy Thanks for providing very important information 👍🙏

The company is backed up by Quadria Capital and the late veteran R J's firm Rare Entetprises. Quadria invested 20% and Rakesh and Rekha Jhunjhunwala invested 24.09% in 2004.
As far as this IPO is concerned, F V is Re 1 and total offer for sale (OFS). Company is not going to receive any fund from this IPO.
The reason of IPO is not abnormal, the company's value is unlocked when the shares are listed on the stock exchanges. At one point of time the investors definitely want to get profit out of the investment done in the company. A normal procedure followed by companies and investors.
Pricing of the issue will be only concern as the f v is Re 1. Hope all will be well.

Some interesting Facts

Promoter Vaid worked with Ranbaxy and Biocon earlier

Intas Pharma & Glenmark Pharma are among top 10 customers

& tagline is '' Biotech for Mankind '' !! :)

Concord Biotech Ipo (Tentative)
Expected pb 700-750
Lot size :- 20

What a coincidence
Windlas Biotech came in 2021
4 to 6 Aug 21
Has still not crossed IPO price .....
Hope this one turns the table!!!!

1) "Objects of the Issue" are childish.
2) 100% OFS

Not worth for longterm. For listing gain will decide later whether to apply or not.

Concord ₹220 buyer only from Ahmedabad

Big hni fix ₹10000 buyer only

Concord ₹300-320 two side done Ahmedabad
1000 qty

i am from ahmedabad. Can you give me your contact details?

GMP please..

RJ backed nice ipo